Literature DB >> 26266638

Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

Aleksandra Gornostaeva1, Elena Andreeva2, Ludmila Buravkova2.   

Abstract

Multipotent mesenchymal stem/stromal cells (MSCs) are of great interest to researchers because of the unique properties, such as enhanced proliferation, paracrine activity and multilineage differentiation. Their non-immunogenicity, in combination with immunomodulatory properties, opens up the opportunity for the allogeneic application of MSCs. The MSC immunomodulatory capacity is currently being actively studied in vitro using various experimental designs. However, the results are not always univocal. It was found that the outcome of the stromal/immune cell interaction depends on experimental conditions. In this review we considered the impact of different factors, such as the ratio of stromal/immune cells, interaction time, the path of immune cell activation, etc. on the MSC immunomodulation. We also accentuated the importance of local milieu, in particular, oxygen tension, for the realization of MSC immunosuppressive activity.

Entities:  

Keywords:  Activation; Cell-to-cell interaction; Immunosuppression; Low oxygen; Lymphocytes; MSCs

Year:  2015        PMID: 26266638      PMCID: PMC4960193          DOI: 10.1007/s10616-015-9906-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  60 in total

1.  [Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a lower oxygen tension].

Authors:  L B Buravkova; O S Grinakovskaia; E P Andreeva; A P Zhambalova; M P Kozionova
Journal:  Tsitologiia       Date:  2009

2.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

Review 3.  Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants.

Authors:  Ching-Shwun Lin; Guiting Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2012-07-03       Impact factor: 3.272

4.  Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice.

Authors:  Weimin Deng; Qin Han; Lianming Liao; Shengguo You; Hongye Deng; Robert C H Zhao
Journal:  DNA Cell Biol       Date:  2005-07       Impact factor: 3.311

5.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

6.  Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice.

Authors:  P Niemeyer; J Vohrer; H Schmal; P Kasten; J Fellenberg; N P Suedkamp; A T Mehlhorn
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

7.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

Authors:  Katarina Le Blanc; Charlotte Tammik; Kerstin Rosendahl; Eva Zetterberg; Olle Ringdén
Journal:  Exp Hematol       Date:  2003-10       Impact factor: 3.084

8.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

9.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.

Authors:  Warren L Grayson; Feng Zhao; Bruce Bunnell; Teng Ma
Journal:  Biochem Biophys Res Commun       Date:  2007-05-22       Impact factor: 3.575

10.  Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

Authors:  Guangwen Ren; Juanjuan Su; Liying Zhang; Xin Zhao; Weifang Ling; Andrew L'huillie; Jimin Zhang; Yongqing Lu; Arthur I Roberts; Weizhi Ji; Huatang Zhang; Arnold B Rabson; Yufang Shi
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more
  5 in total

1.  Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

Authors:  Andrea Gray; Rene S Schloss; Martin Yarmush
Journal:  Technology (Singap World Sci)       Date:  2016-09

2.  Interaction of allogeneic adipose tissue-derived stromal cells and unstimulated immune cells in vitro: the impact of cell-to-cell contact and hypoxia in the local milieu.

Authors:  Aleksandra N Gornostaeva; Elena R Andreeva; Polina I Bobyleva; Ludmila B Buravkova
Journal:  Cytotechnology       Date:  2017-10-03       Impact factor: 2.058

3.  Allogeneic transplantation of mobilized dental pulp stem cells with the mismatched dog leukocyte antigen type is safe and efficacious for total pulp regeneration.

Authors:  Koichiro Iohara; Shinji Utsunomiya; Sakae Kohara; Misako Nakashima
Journal:  Stem Cell Res Ther       Date:  2018-04-27       Impact factor: 6.832

Review 4.  Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke.

Authors:  Yingchen Li; Qilai Cheng; Guoheng Hu; Tianhao Deng; Qimei Wang; Jianda Zhou; Xinping Su
Journal:  Exp Ther Med       Date:  2018-03-22       Impact factor: 2.447

5.  Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells.

Authors:  Xiaoyan Han; Tao Na; Tingting Wu; Bao-Zhu Yuan
Journal:  PLoS One       Date:  2020-01-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.